# The Effect of Exercise on Pharmacodynamics and Pharmacokinetics of a Single Dose of Unfractionated Heparin

> **NCT06174961** · PHASE4 · COMPLETED · sponsor: **Kristian Karstoft** · enrollment: 23 (actual)

## Conditions studied

- Blood Coagulation Disorder

## Interventions

- **DRUG:** Unfractionated heparin
- **BEHAVIORAL:** Double-legged cycle ergometer exercise
- **BEHAVIORAL:** Single-legged cycle ergometer exercise, with unfractionated heparin injection in the exercising leg
- **BEHAVIORAL:** Single-legged cycle ergometer exercise, with unfractionated heparin injection in the non-exercising leg
- **BEHAVIORAL:** No exercise

## Key facts

- **NCT ID:** NCT06174961
- **Lead sponsor:** Kristian Karstoft
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-22
- **Primary completion:** 2024-02-13
- **Final completion:** 2024-05-01
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2024-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06174961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06174961, "The Effect of Exercise on Pharmacodynamics and Pharmacokinetics of a Single Dose of Unfractionated Heparin". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06174961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*